Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 9, 1998, Pages 916-922

  Slomiany, B L ^a,b   Piotrowski, J ^a   Slomiany, A ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Apoptosis; Gastritis; Helicobacter pylori; Interleukin 4; Lipopolysaccharide; Sucralfate; Tumor necrosis factor alpha

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 13; INTERLEUKIN 4; SUCRALFATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; EPITHELIUM CELL; GASTRITIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; RISK FACTOR; STOMACH MUCOSA;

ANIMALS; ANTI-ULCER AGENTS; APOPTOSIS; GASTRIC MUCOSA; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; SUCRALFATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031758478     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655298750026912     Document Type: Article

References (40)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89:S116-28.
2. Rune SJ. History of Helicobacter infection. Scand J Gastroenterol 1996;31 Suppl 214:2-4.
3. Stolte M, Edit S. Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol 1996;31 Suppl 214:13-6.
4. Hunt RH, Mohamed AH. The current role of H. pylori eradication in clinical practice. Scand J Gastroenterol 1995;30 Suppl 208:47-52.
5. Figura N, Crabtree IE. H. pylori vacuolating toxin. In: Hunt RH, Tytgat GNJ, editors. Helicobacter pylori: basic mechanism to clinical cure. Dordrecht: Kulwer Academic Publisher; 1994. p. 222-31.
6. Lichtenberger LA, Dial EJ, Romero JJ, Lechago J, Jarboe LA, Wolfe MM. Role of luminal ammonia in the development of gastropathy and hypergastrinemia in the rat. Gastroenterology 1995;108:320-9.
7. Slomiany BL, Piotrowski J, Slomiany A. Suppression of Helicobacter pylori urease activity by sucralfate and sulglycotide. Biochem Mol Biol Int 1997;42:155-61.
8. Piotrowski J, Majka J, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor. Biochem Mol Biol Int 1995;36:491-8.
9. Piotrowski J, Slomiany A, Slomiany BL. H. pylori lipopolysaccharide inhibition of gastric somatostatin receptor: effect of sucralfate. Biochem Mol Biol Int 1997;42:545-51.
10. Tomkins LS, Falkow S. The new path to prevent ulcers. Science 1995;267:1621-2.
11. Harris PR, Mobley HLT, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996;111:419-25.
12. Eaton KA, Catrenick CE, Malkin KM, Krakowka S. Virulence of coccoid and bacillary forms of H. pylori in gnotobiotic piglets. J Infect Dis 1995;171:459-62.
13. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by H. pylori in gnotobiotic piglets. Infect Immun 1991;59:2470-5.
14. Slomiany BL, Murty VLN, Piotrowski J, Slomiany A. Gastroprotective agents in mucosal defense against H. pylori. Gen Pharmacol 1994;25:833-41.
15. Slomiany A, Piotrowski J, Slomiany BL. Sucralfate inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide. Scand J Gastroenterol 1995;30 Suppl 210:77-83.
16. Slomiany BL, Piotrowski J, Slomiany A. Anti-H. pylori activities of ebrotidine. Arzneimittelforsch Drug Res 1997;47: 475-82.
17. Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide induces gastric epithelial cell apoptosis. Biochem Mol Biol Int 1996;40:597-602.
18. Piotrowski J, Piotrowski E, Skrodzka D, Slomiany A, Slomiany BL. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 1997;32:203-11.
19. Moss SF, Calam J, Agarawal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38:498-501.
20. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
21. Mijatovic T, Kruys V, Caput D, Defrance P, Huez G. Interleukin-4 and -13 inhibit tumor necrosis factor-α mRNA translational activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997;272:1494-8.
22. Orchansky PL, Ayres SD, Hilton DJ, Schrader JW. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4. J Biol Chem 1997;272:22940-7.
23. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209-22.
24. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen MC, Tytgat GNJ. Campylobacter pylori-associated chronic active antral gastritis. A prospective study of its prevalence and the effect of antibacterial and antiulcer treatment. Gastroenterology 1988; 94:33-40.
25. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55kDa receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995;154:1307-16.
26. Slomiany BL, Piotrowski J, Slomiany A. Induction of tumor necrosis factor-α and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine. Scand J Gastroenterol 1997;32:638-42.
27. Slomiany BL, Piotrowski J, Slomiany A. Chronic alcohol ingestion enhances tumor necrosis factor-α expression and salivary gland apoptosis. Alcohol Clin Exp Res 1997;21:1530-3.
28. Slomiany BL, Piotrowski J, Rajiah G, Slomiany A. Inhibition of gastric mucosal laminin receptor by H. pylori lipopolysaccharide: effect of nitecapone. Gen Pharmacol 1991;22:1063-9.
29. Crabtree JE, Shallcross TM, Heatly RV, Wyatt JL. Mucosal tumor necrosis factor alpha and interleukin 6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
30. Crabtree JE, Peichl P, Wyatt JL, Stachl U, Lindley IJ. Gastric interleukin 8 and IgA IL-8 antibodies in Helicobacter pylori infection. Scand J Gastroenterol 1993;37:65-70.
31. Moss SF, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori associated gastritis. Gut 1994;35:1567-70.
32. Jin F, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997;88:417-26.
33. Wallach D. Cell death induction by TNF: a matter of self control. TIBS 1997;22:107-9.
34. Villa P, Kaufmann SH, Earnshaw WC. Caspases and caspase inhibitors. TIBS 1997;22:388-93.
35. Beales I, Blaser MJ, Srinivasan S, Calam J, Perez-Perez GI, Yamada T, et al. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 1997;113:465-71.
36. Velasco M, Diaz-Guerra MJM, Martin-Sanz P, Alvarez A, Bosca L. Rapid up-regulation of IκBβ and abrogation of NF-κB activity in peritoneal macrophages stimulated with lipopolysaccharide. J Biol Chem 1997;272:23025-30.
37. Terano A, Shimada T, Hiraishi H. Sucralfate and Helicobacter pylori. J Gastroenterol 1996;31 Suppl IX:63-5.
38. Winter TA, Louw JA, Marks IN, Jaskewicz K, Lucke W, Callanan M. Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer. Scand J Gastroenterol 1995;30 Suppl 210:85-8.
39. Banerjee S, El-Omar E, Mowat A, Ardill JES, Park RHR, Watson W, et al. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology 1996;110:717-24.
40. Hui WM, Lam SK, Ho J, Ng I, Lau WY, Branicki FJ, et al. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. Am J Med 1988;86 Suppl 6A:60-5.